CA

Charles Antoine Janssen

Active Director Nominee Director DIN 01266976
DIN 01266976 First appointment Feb 2007 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 6 historical roles
Total affiliations 15 Since Feb 2007
Shareholding value Locked Premium profile

About Charles Antoine Janssen

Charles Antoine Janssen has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 9 companies, including Sekhmet Technologies Private Limited and Touchkin Eservices Private Limited. Formerly with 6 companies, such as Panacea Medical Technologies Private Limited and Maxxess Technology Private Limited. Engaged in Technology, General Business and more.

DIN 01266976
Primary Designation Nominee Director
First Appointment 28 Feb 2007
Oldest Company Age 23 yrs

Current companies

Company Designation Appointment Founded Status
Sekhmet Technologies Private Limited U72200HR2015PTC056692
Nominee Director 25 Mar 2021 2015 Active
Touchkin Eservices Private Limited U72200KA2015PTC078356
Nominee Director 01 Sep 2022 2015 Active
Neurosynaptic Communications Private Limited U73100KA2002PTC031023
Nominee Director 08 Oct 2021 2002 Active
Healthquad Capital Advisors Private Limited U74999DL2019PTC352056
Director 13 Nov 2019 2019 Active
Qure.Ai Technologies Private Limited U74999MH2016PTC283891
Director 13 Apr 2022 2016 Active
Kois India Investment Advisors Private Limited U74999MH2017PTC292186
Director 08 Mar 2017 2017 Active
Tech Care For All India Private Limited U74999MH2018PTC318729
Director 26 Dec 2018 2018 Active
Neonatal Care & Research Institute Private Limited U85110KA2011PTC060298
Nominee Director 29 Sep 2021 2011 Active

Previous companies

Company Designation Appointment Founded Status
Panacea Medical Technologies Private Limited U33112KA1999PTC079963
Nominee Director 05 Oct 2021 1999 Active
Maxxess Technology Private Limited U74999MH2017PTC289641
Director 01 Mar 2018 2017 Under Process Of Striking Off
Regency Hospital Limited U85110UP1987PLC008792
Nominee Director 28 Feb 2017 1987 Active
Organisation Of Pharmaceutical Producers Of India U91120MH1965GAP013389
Director 19 Sep 2008 1965 Active
Indo-Belgian Luxembourg Chamber Of Commerce And Industry U91120MH2001NPL132596
Director 28 Nov 2007 2001 Active
Ucb India Private Limited U62090MH1959PTC011545
Managing Director 28 Feb 2007 1959 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sekhmet Technologies Private Limited
Touchkin Eservices Private Limited
Neurosynaptic Communications Private Limited
Healthquad Capital Advisors Private Limited
Premium access

Shareholding and investment profile for Charles Antoine Janssen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charles Antoine Janssen

Charles Antoine Janssen has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 9 companies, including Sekhmet Technologies Private Limited and Touchkin Eservices Private Limited. Formerly with 6 companies, such as Panacea Medical Technologies Private Limited and Maxxess Technology Private Limited. Engaged in Technology, General Business and more.

Charles Antoine Janssen is associated with 9 companies as Nominee Director and Director.

Charles Antoine Janssen has expertise in Technology, General Business and other sectors.

Charles Antoine Janssen has 19 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available